The average Novartis Pharmaceuticals Financial Analyst in New York earns an estimated $94,919 annually, which includes an estimated base salary of $82,339 with a $12,580 bonus. Novartis Pharmaceuticals' Financial Analyst compensation is $7,520 more than the US average for a Financial Analyst. Financial Analyst salaries at Novartis Pharmaceuticals in New York can range from $54,000 - $150,000.
In New York, The Finance Department at Novartis Pharmaceuticals earns $12,001 more on average than the Design Department.
Last updated 2 years ago.
In New York, Financial Analysts earn $2,919 more than Financial Analysts, and $9,624 less than Accounting Managers.
In New York, The Finance Department averages $12,001 more than the Design Department, and $654 less than the Operations Department
The average female Financial Analyst at companies similar size to Novartis Pharmaceuticals reported making $93,556, while the average male Financial Analyst at similar sized companies reported making $91,853.
The average Asian or Pacific Islander Financial Analyst at companies similar size to Novartis Pharmaceuticals reported making $98,729, while the average Native American Financial Analyst at similar sized companies reported making $60,000.
The majority of Financial Analysts at Novartis Pharmaceuticals believe they're compensated fairly. 100% of Financial Analysts at Novartis Pharmaceuticals say they receive annual bonuses, and the vast majority (79%) are satisfied with their benefits. See more compensation ratings at Novartis Pharmaceuticals